Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HIV and vitamins

This article was originally published in The Tan Sheet

Executive Summary

A clinical trial on multivitamins and HIV progression "included a large sample and had adequate statistical power to detect an effect on clinical outcomes," Wafaie Fawzi, Dr/Ph, Harvard School of Public Health, et al. argue in the Sept. 23 New England Journal of Medicine. The researchers write in defense of their study published in the July 1 issue showing multivitamins significantly reduced HIV progression and symptoms in pregnant Tanzanian women (1"The Tan Sheet" July 5, 2004, p. 15). Katharina Schroecksnadel, MD, et al., Innsbruck Medical University, Austria, suggest the most impressive result of Fawzi's study is "the effects of vitamins on the immune system, on disease progression, and on mortality appear to be secondary to immune-system restoration." Fawzi et al. suggest the next trial evaluating early stages of HIV should evaluate nutrients that were not included in the first study, such as selenium...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS097331

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel